These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23402315)

  • 1. Oral administration of methylphenidate blocks the effect of cocaine on uptake at the Drosophila dopamine transporter.
    Berglund EC; Makos MA; Keighron JD; Phan N; Heien ML; Ewing AG
    ACS Chem Neurosci; 2013 Apr; 4(4):566-74. PubMed ID: 23402315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
    Calipari ES; Ferris MJ; Siciliano CA; Jones SR
    ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.
    Spencer TJ; Biederman J; Ciccone PE; Madras BK; Dougherty DD; Bonab AA; Livni E; Parasrampuria DA; Fischman AJ
    Am J Psychiatry; 2006 Mar; 163(3):387-95. PubMed ID: 16513858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
    Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
    Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR
    Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.
    Spencer TJ; Bonab AA; Dougherty DD; Mirto T; Martin J; Clarke A; Fischman AJ
    J Clin Psychiatry; 2012 Mar; 73(3):346-52. PubMed ID: 22154896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
    Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
    Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using In Vivo Electrochemistry to Study the Physiological Effects of Cocaine and Other Stimulants on the Drosophila melanogaster Dopamine Transporter.
    Makos MA; Han KA; Heien ML; Ewing AG
    ACS Chem Neurosci; 2010 Jan; 1(1):74-83. PubMed ID: 20352129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the dopamine transporter in Drosophila larva.
    Vickrey TL; Xiao N; Venton BJ
    ACS Chem Neurosci; 2013 May; 4(5):832-7. PubMed ID: 23600464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo electrochemical measurements of exogenously applied dopamine in Drosophila melanogaster.
    Makos MA; Kim YC; Han KA; Heien ML; Ewing AG
    Anal Chem; 2009 Mar; 81(5):1848-54. PubMed ID: 19192966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine.
    Gatley SJ; Volkow ND; Gifford AN; Ding YS; Logan J; Wang GJ
    Biochem Pharmacol; 1997 Jan; 53(1):43-52. PubMed ID: 8960062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
    Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
    Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of endogenous dopamine changes in Drosophila melanogaster using fast-scan cyclic voltammetry.
    Vickrey TL; Condron B; Venton BJ
    Anal Chem; 2009 Nov; 81(22):9306-13. PubMed ID: 19842636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.
    Robison LS; Ananth M; Hadjiargyrou M; Komatsu DE; Thanos PK
    J Neural Transm (Vienna); 2017 May; 124(5):655-667. PubMed ID: 28116523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
    Harvey RC; Sen S; Deaciuc A; Dwoskin LP; Kantak KM
    Neuropsychopharmacology; 2011 Mar; 36(4):837-47. PubMed ID: 21150910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
    Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.
    Calipari ES; Ferris MJ; Melchior JR; Bermejo K; Salahpour A; Roberts DC; Jones SR
    Addict Biol; 2014 Mar; 19(2):145-55. PubMed ID: 22458761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster.
    Highfill CA; Baker BM; Stevens SD; Anholt RRH; Mackay TFC
    PLoS Genet; 2019 May; 15(5):e1007834. PubMed ID: 31107875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
    Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.
    Yorgason JT; Jones SR; España RA
    Neuroscience; 2011 May; 182():125-32. PubMed ID: 21402130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.